Testing effectiveness (Phase 2)Study completedNCT00290251
What this trial is testing
Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914
Who this might be right for
Leiomyoma
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 72